AU2002351176A8 - Peptides and use thereof in therapeutic agents against hiv infection - Google Patents

Peptides and use thereof in therapeutic agents against hiv infection

Info

Publication number
AU2002351176A8
AU2002351176A8 AU2002351176A AU2002351176A AU2002351176A8 AU 2002351176 A8 AU2002351176 A8 AU 2002351176A8 AU 2002351176 A AU2002351176 A AU 2002351176A AU 2002351176 A AU2002351176 A AU 2002351176A AU 2002351176 A8 AU2002351176 A8 AU 2002351176A8
Authority
AU
Australia
Prior art keywords
peptides
therapeutic agents
hiv infection
against hiv
agents against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2002351176A
Other versions
AU2002351176A1 (en
Inventor
Pierre-Francois Serre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mymetics Corp
Original Assignee
Mymetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0115423A external-priority patent/FR2832715A1/en
Application filed by Mymetics Corp filed Critical Mymetics Corp
Publication of AU2002351176A1 publication Critical patent/AU2002351176A1/en
Publication of AU2002351176A8 publication Critical patent/AU2002351176A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2002351176A 2001-11-29 2002-11-27 Peptides and use thereof in therapeutic agents against hiv infection Abandoned AU2002351176A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0115423 2001-11-29
FR0115423A FR2832715A1 (en) 2001-11-29 2001-11-29 New peptide containing 25 - 40 amino acids and a sequence useful as therapeutic agents in the treatment of HIV virus infections
US34049201P 2001-12-18 2001-12-18
US60/340,492 2001-12-18
PCT/US2002/038152 WO2003048187A2 (en) 2001-11-29 2002-11-27 Peptides and use thereof in therapeutic agents against hiv infection

Publications (2)

Publication Number Publication Date
AU2002351176A1 AU2002351176A1 (en) 2003-06-17
AU2002351176A8 true AU2002351176A8 (en) 2003-06-17

Family

ID=26213281

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002351176A Abandoned AU2002351176A1 (en) 2001-11-29 2002-11-27 Peptides and use thereof in therapeutic agents against hiv infection

Country Status (2)

Country Link
AU (1) AU2002351176A1 (en)
WO (1) WO2003048187A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140335119A1 (en) * 2004-02-06 2014-11-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) POLYPEPTIDE DERIVED FROM gp41, A VACCINE COMPOSITION COMPRISING SAID POLYPEPTIDE, AND USES FOR TREATING AN INFECTION BY AN HIV VIRUS IN AN INDIVIDUAL
US20150175666A1 (en) * 2012-06-27 2015-06-25 Yeda Research And Development Co. Ltd. Peptides derived from hiv gp41 for treating t-cell mediated pathologies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444044A (en) * 1992-03-26 1995-08-22 New York Blood Center Synthetic polypeptides as inhibitors of HIV-1
WO1994002505A1 (en) * 1992-07-20 1994-02-03 Duke University Compounds which inhibit hiv replication
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission

Also Published As

Publication number Publication date
WO2003048187A3 (en) 2004-04-29
AU2002351176A1 (en) 2003-06-17
WO2003048187A2 (en) 2003-06-12

Similar Documents

Publication Publication Date Title
GB0111872D0 (en) Therapeutic agents and methods
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
EP1367060A4 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
EP1364957A4 (en) Glycopyranosyloxypyrazole derivatives and medicinal use thereof
EP1364958A4 (en) Glycopyranosyloxypyrazole derivatives and medicinal use thereof
HUP0301003A3 (en) Casein derived peptides and uses thereof in therapy
IL156565A0 (en) N-(phenylsulphonyl) glycine derivatives and their therapeutic use
AU2002346504A8 (en) Therapeutic protein and treatments
AU6723401A (en) Antimicrobial peptides and methods of use thereof
EP1578769A4 (en) Peptides and the use thereof in darkening the skin
HUP0402318A3 (en) Pharmaceutical composition comprising cyclosporin and use thereof
SI1462455T1 (en) Ser-Ser-Ser-Arg peptide and medicinal uses thereof
EP1554306A4 (en) Conjugates comprised of polymer and hiv gp41-derived peptides and their use in therapy
HUP0500995A3 (en) Casein derived peptides and uses thereof in therapy
HUP0400262A3 (en) Glycopeptides, their preparation and use in the treatment of multiple sclerosis
GB0011052D0 (en) Medical device and use thereof
GB0026134D0 (en) Peptides and their use
AU2002351176A8 (en) Peptides and use thereof in therapeutic agents against hiv infection
EP1308509A4 (en) Novel physiologically active peptide and use thereof
EP1357129A4 (en) Novel physiologically active peptide and use thereof
GB0018887D0 (en) Compound and their therapeutic use
EP1224939A4 (en) Interferon complex and medicinal use thereof
EP1275659A4 (en) Novel physiologically active peptides and use thereof
GB0017028D0 (en) Peptides and their therapeutic use
AU2002324731A1 (en) New peptides and use thereof in therapeutic agents against feline fiv infection

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase